-
Delavirdine (DLV) (brand name Rescriptor) is a non-nucleoside
reverse transcriptase inhibitor (NNRTI)
marketed by ViiV Healthcare. It is used as part...
-
Amprenavir (HIV
protease inhibitor)
Darunavir (HIV
protease inhibitor)
Delavirdine (non-nucleoside
reverse transcriptase inhibitor)
Fosamprenavir (HIV protease...
-
certain azole antifungals (e.g., ketoconazole, itraconazole, voriconazole)
delavirdine, efavirenz, or a 5-HT1
receptor agonist (e.g., sumatriptan). Side effects...
- with,
among other drugs:
sucralfate ampicillin bisacodyl clopidogrel delavirdine fluvoxamine iron
salts voriconazole aminophylline and
theophylline astemizole...
-
revoked in
September 2016.
Abacavir Amprenavir Atazanavir Darunavir Delavirdine Didanosine (ddI)
Dolutegravir Efavirenz Enfuvirtide Stavudine (d4T) Etravirine...
-
Retrovir and AZT) Non-nucleoside
reverse transcriptase inhibitors (NNRTIs):
delavirdine (brand name Rescriptor, no
longer available)
Attachment inhibitors fostemsavir...
-
Trimazosin Umespirone Zalospirone Pyridinylpiperazines Atevirdine Azaperone Delavirdine Mirtazapine ORG-12962
Pyridinylpiperazine Benzo(iso)thiazolylpiperazines...
- (Daklinza)
Hepatitis C NS5A
inhibitor Darunavir HIV
antiretroviral HIV PI
Delavirdine HIV
antiretroviral NNRTI Descovy (Emtricitabine/tenofovir alafenamide)...
-
Trimazosin Umespirone Zalospirone Pyridinylpiperazines Atevirdine Azaperone Delavirdine Mirtazapine ORG-12962
Pyridinylpiperazine Benzo(iso)thiazolylpiperazines...
-
contraindicated in HIV
positive patients taking protease inhibitors,
delavirdine, and
efavirenz (which is also an
agonist at the 5-HT2A–mGlu2 receptor...
